Recovery

GHK-Cu

Mechanism

A copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine bound to Cu(II)). Modulates gene expression to stimulate collagen, elastin, and stem-cell activation. Active topically and via injection. Endogenous levels decline ~60% by age 60.

Typical dose

1-2mg per injection, 2-3 times per week (injectable). 0.05-2% (topical formulations).

Cycle length

12-24 weeks; topical can be continuous

Form

Injectable (subcutaneous), topical serum

Deep dives on GHK-Cu

Best Peptide Protocol for Knee Cartilage Repair and Osteoarthritis Pain (2026)Evidence-based guide to peptide protocol for knee cartilage repair: BPC-157, TB-500, GHK-Cu mechanisms, intra-articular dosing, contraindications, and 2026 regulatory
Can Peptides Help Cure Loss of Smell? Evidence on Anosmia and Olfactory Repair (2026)Peptides for anosmia have compelling mechanisms but zero human RCT evidence. We examine why clinical adoption has stalled and what the science actually supports.
6 Best Peptides for Anti-Ageing and Longevity (2026)The anti-ageing peptide consensus is wrong. We rank epitalon, MOTS-c, and GHK-Cu by what the primary literature actually proves vs what marketing narratives claim.
CJC-1295 Complete Guide: Growth Hormone Releaser, Mechanism, Dosing, and Cycle Length (2026)The 6-to-14-day elevation window in CJC-1295 is oversold. We interrogate the primary literature, the desensitisation risk, and DAC vs. no-DAC trade-offs honestly.
BPC-157 and TB-500 Post-Surgery Recovery Protocol: When to Start, Dosing, and Cycle Length (2026)BPC-157 and TB-500 post-surgery recovery: when to start, dosing, cycle length, and what the evidence supports for accelerated soft-tissue healing.

Get the Pre-Protocol Checklist

Free checklist plus weekly protocols, research breakdowns, and tactical guides. No spam. Unsubscribe anytime.